Eculizumab as a treatment for atypical hemolytic uremic syndrome secondary to carfilzomib

1. Moliz, C.
2. Gutiérrez, E.
3. Cavero, T.
4. Redondo, B.
5. Praga, M.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.NEFROE.2018.02.017 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus